Cargando…
Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943423/ https://www.ncbi.nlm.nih.gov/pubmed/32873913 http://dx.doi.org/10.1038/s41409-020-01047-2 |
| _version_ | 1783662489210191872 |
|---|---|
| author | Xu, Xiaoqian Yang, Jun Cai, Yu Li, Su Niu, Jiahua Zhou, Kun Jiang, Ying Xu, Xiaowei Shen, Chang Huang, Chongmei Qiu, Huiying Wei, Daolin Kang, Mei Tong, Yin Wei, Zheng Liu, Peng Wan, Liping Song, Xianmin |
| author_facet | Xu, Xiaoqian Yang, Jun Cai, Yu Li, Su Niu, Jiahua Zhou, Kun Jiang, Ying Xu, Xiaowei Shen, Chang Huang, Chongmei Qiu, Huiying Wei, Daolin Kang, Mei Tong, Yin Wei, Zheng Liu, Peng Wan, Liping Song, Xianmin |
| author_sort | Xu, Xiaoqian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7943423 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79434232021-03-28 Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood Xu, Xiaoqian Yang, Jun Cai, Yu Li, Su Niu, Jiahua Zhou, Kun Jiang, Ying Xu, Xiaowei Shen, Chang Huang, Chongmei Qiu, Huiying Wei, Daolin Kang, Mei Tong, Yin Wei, Zheng Liu, Peng Wan, Liping Song, Xianmin Bone Marrow Transplant Correspondence Nature Publishing Group UK 2020-09-01 2021 /pmc/articles/PMC7943423/ /pubmed/32873913 http://dx.doi.org/10.1038/s41409-020-01047-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Xu, Xiaoqian Yang, Jun Cai, Yu Li, Su Niu, Jiahua Zhou, Kun Jiang, Ying Xu, Xiaowei Shen, Chang Huang, Chongmei Qiu, Huiying Wei, Daolin Kang, Mei Tong, Yin Wei, Zheng Liu, Peng Wan, Liping Song, Xianmin Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title | Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title_full | Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title_fullStr | Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title_full_unstemmed | Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title_short | Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| title_sort | low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose atg/ptcy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943423/ https://www.ncbi.nlm.nih.gov/pubmed/32873913 http://dx.doi.org/10.1038/s41409-020-01047-2 |
| work_keys_str_mv | AT xuxiaoqian lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT yangjun lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT caiyu lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT lisu lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT niujiahua lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT zhoukun lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT jiangying lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT xuxiaowei lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT shenchang lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT huangchongmei lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT qiuhuiying lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT weidaolin lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT kangmei lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT tongyin lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT weizheng lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT liupeng lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT wanliping lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco AT songxianmin lowdoseantithymocyteglobulinwithlowdoseposttransplantcyclophosphamidelowdoseatgptcycanreducetheriskofgraftversushostdiseaseascomparedwithstandarddoseantithymocyteglobulininhaploidenticalperipheralhematopoieticstemcelltransplantationcombinedwithunrelatedco |